Francesca Benevento

1.0k total citations
19 papers, 699 citations indexed

About

Francesca Benevento is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Francesca Benevento has authored 19 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 6 papers in Epidemiology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Francesca Benevento's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer Mechanisms and Therapy (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Francesca Benevento is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer Mechanisms and Therapy (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Francesca Benevento collaborates with scholars based in Italy, Romania and United Kingdom. Francesca Benevento's co-authors include Fabio Piscaglia, Alessandro Granito, Sara Marinelli, Francesco Tovoli, Matteo Renzulli, Luigi Bolondi, Giulia Negrini, Alicia Tosoni, R. Agati and Alba A. Brandes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Cancer Research.

In The Last Decade

Francesca Benevento

19 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Benevento Italy 11 299 215 182 174 168 19 699
Hao Xing China 16 530 1.8× 200 0.9× 303 1.7× 37 0.2× 191 1.1× 30 982
Yuko Kakuda Japan 18 207 0.7× 315 1.5× 152 0.8× 46 0.3× 119 0.7× 52 931
Olugbenga Olowokure United States 14 61 0.2× 156 0.7× 88 0.5× 66 0.4× 162 1.0× 35 513
Carmela Iglesias Spain 10 291 1.0× 108 0.5× 262 1.4× 18 0.1× 289 1.7× 38 840
Giulia Orsi Italy 12 89 0.3× 148 0.7× 49 0.3× 32 0.2× 171 1.0× 34 514
Masayuki Otsuka Japan 15 122 0.4× 121 0.6× 126 0.7× 24 0.1× 343 2.0× 73 847
E. Joosens Belgium 11 59 0.2× 173 0.8× 41 0.2× 225 1.3× 133 0.8× 26 587
Tahir Latif United States 13 47 0.2× 108 0.5× 74 0.4× 91 0.5× 211 1.3× 38 588
Pamela Biondani Italy 12 71 0.2× 162 0.8× 92 0.5× 29 0.2× 104 0.6× 37 505
Emmanuel Mitry France 11 511 1.7× 202 0.9× 427 2.3× 38 0.2× 106 0.6× 22 1.2k

Countries citing papers authored by Francesca Benevento

Since Specialization
Citations

This map shows the geographic impact of Francesca Benevento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Benevento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Benevento more than expected).

Fields of papers citing papers by Francesca Benevento

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Benevento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Benevento. The network helps show where Francesca Benevento may publish in the future.

Co-authorship network of co-authors of Francesca Benevento

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Benevento. A scholar is included among the top collaborators of Francesca Benevento based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Benevento. Francesca Benevento is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Benevento, Francesca, Anna Pecorelli, Horia Ştefănescu, et al.. (2023). Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients. Journal of Hepatocellular Carcinoma. Volume 10. 473–482. 3 indexed citations
2.
Granito, Alessandro, Sara Marinelli, A. Forgione, et al.. (2021). Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC. Journal of Hepatocellular Carcinoma. Volume 8. 477–492. 26 indexed citations
3.
Granito, Alessandro, A. Forgione, Sara Marinelli, et al.. (2021). Experience with regorafenib in the treatment of hepatocellular carcinoma. Therapeutic Advances in Gastroenterology. 14. 1088199935–1088199935. 100 indexed citations
4.
Ielasi, Luca, et al.. (2021). An update on atezolizumab for hepatocellular carcinoma. Drugs of today. 57(6). 365–365. 1 indexed citations
5.
Gramantieri, Laura, Daniela Pollutri, Martina Gagliardi, et al.. (2020). MiR-30e-3p Influences Tumor Phenotype through MDM2 / TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma. Cancer Research. 80(8). 1720–1734. 50 indexed citations
6.
Tovoli, Francesco, Massimo Iavarone, Letizia Veronese, et al.. (2020). Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis. Liver Cancer. 9(6). 744–755. 15 indexed citations
7.
Mulazzani, Lorenzo, Francesco Tovoli, Simona Leoni, et al.. (2020). Moderate alcohol consumption is associated with risk of fibrosis in patients with non-alcoholic fatty liver disease. Digestive and Liver Disease. 52. e43–e44. 1 indexed citations
8.
Ielasi, Luca, et al.. (2020). Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery. SHILAP Revista de lepidopterología. 7(3). HEP24–HEP24. 3 indexed citations
9.
Tovoli, Francesco, Andrea Casadei‐Gardini, Francesca Benevento, & Fabio Piscaglia. (2019). Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019. Digestive and Liver Disease. 51(8). 1067–1073. 18 indexed citations
10.
Ielasi, Luca, Vito Sansone, Alessandro Granito, et al.. (2018). An update of treatments of hepatocellular carcinoma in patientsrefractory to sorafenib. Drugs of today. 54(10). 615–615. 7 indexed citations
11.
Tovoli, Francesco, Matteo Renzulli, Giulia Negrini, et al.. (2018). Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib. European Radiology. 28(9). 3611–3620. 56 indexed citations
12.
Tovoli, Francesco, et al.. (2018). Systemic treatments for hepatocellular carcinoma: challenges and future perspectives. SHILAP Revista de lepidopterología. 5(1). HEP01–HEP01. 31 indexed citations
13.
Tovoli, Francesco, Stefania De Lorenzo, Boaz Gedaliahu Samolsky Dekel, et al.. (2017). Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma. Liver International. 38(2). 278–284. 9 indexed citations
14.
Terzi, Eleonora, Simona Leoni, Francesca Benevento, et al.. (2017). CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules. Journal of Hepatology. 66(1). S208–S209. 3 indexed citations
15.
Terzi, Eleonora, Simona Leoni, Francesca Benevento, et al.. (2017). CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules. Digestive and Liver Disease. 49(1). e22–e22. 10 indexed citations
16.
Granito, Alessandro, et al.. (2015). Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib. Therapeutic Advances in Gastroenterology. 9(2). 240–249. 65 indexed citations
17.
Granito, Alessandro, Sara Marinelli, Eleonora Terzi, et al.. (2015). Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure. Digestive and Liver Disease. 47(6). 518–522. 71 indexed citations
18.
Leoni, Simona, Fabio Piscaglia, Ilaria Serio, et al.. (2014). Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group. Digestive and Liver Disease. 46(6). 549–555. 49 indexed citations
19.
Brandes, Alba A., Enrico Franceschi, Alicia Tosoni, et al.. (2009). Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma. Cancer. 115(15). 3512–3518. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hao Xing Breakdown of academic impact, for papers by Yuko Kakuda Breakdown of academic impact, for papers by Olugbenga Olowokure Breakdown of academic impact, for papers by Carmela Iglesias Breakdown of academic impact, for papers by Giulia Orsi Breakdown of academic impact, for papers by Masayuki Otsuka Breakdown of academic impact, for papers by E. Joosens Breakdown of academic impact, for papers by Tahir Latif Breakdown of academic impact, for papers by Pamela Biondani Breakdown of academic impact, for papers by Emmanuel Mitry
Rankless by CCL
2026